A rapid systematic review of measures to protect older people in long term care facilities from COVID-19
========================================================================================================

* Kate Frazer
* Lachlan Mitchell
* Diarmuid Stokes
* Ella Lacey
* Eibhlin Crowley
* Cecily Kelleher

## Abstract

The global COVID-19 pandemic produced large-scale health and economic complications. Older people and those with comorbidities are particularly vulnerable to this virus, with nursing homes and long term care facilities experiencing significant morbidity and mortality associated with COVID-19 outbreaks. The aim of this rapid systematic review was to investigate measures implemented in long term care facilities to reduce transmission of COVID-19 and their effect on morbidity and mortality of residents, staff, and visitors. Databases (including MedRXiv pre-published repository) were systematically searched to identify studies reporting assessment of interventions to reduce transmission of COVID-19 in nursing homes among residents, staff, or visitors. Outcome measures include facility characteristics, morbidity data, case fatalities, and transmission rates. Due to study quality and heterogeneity, no meta-analysis was conducted. The search yielded 1414 articles, with 38 studies included. Reported interventions include mass testing, use of personal protective equipment, symptom screening, visitor restrictions, hand hygiene and droplet/contact precautions, and resident cohorting. Prevalence rates ranged from 1.2-85.4% in residents and 0.6-62.6% in staff. Mortality rates ranged from 5.3-55.3% in residents. Novel evidence in this review details the impact of facility size, availability of staff and practices of operating between multiple facilities, and for-profit status of facilities as factors contributing to the size and number of COVID-19 outbreaks. No causative relationships can be determined; however, this review provides evidence of interventions that reduce transmission of COVID-19 in long term care facilities.

Keywords
*   Coronavirus
*   COVID-19
*   nursing homes
*   transmission

## Introduction

Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is a novel virus, first identified in China in 2019, resulting in the current global pandemic in 2020.1 The ensuing disease associated with infection from SARS-CoV-2, termed COVID-19, has produced large-scale public health and worldwide economic effects.2

The virus spreads between people through close contact and droplet transmission (coughs and sneezes). While most infected people will experience mild flu□like symptoms, others may become seriously ill and die.3 At-risk groups include older people and those with underlying medical conditions, while men appear to have more susceptibility than women. Symptom severity varies; several individuals remain asymptomatic, others experience fever, cough, sore throat, general weakness, and fatigue, while more severe respiratory illnesses and infections may result, which can be fatal.4,5 Deterioration in clinical presentations can occur rapidly, leading to poorer health outcomes. Anosmia and ageusia are reported in evidence from South Korea, China, and Italy in patients with confirmed SARS-CoV-2 infection, in some cases in the absence of other symptoms.6

The World Health Organization (WHO) declared the COVID-19 outbreak constituted a Public Health Emergency of International Concern (PHEIC) on January 30, 2020.5 Two primary goals of action were 1) to accelerate innovative research to help contain the spread and facilitate care for all affected, and 2) to support research priorities globally the learning from the pandemic response for preparedness. Globally, up to October 5, 2020, there are 35 247 104 cases of COVID-19 (following the applied case definitions and testing strategies in the affected countries) including 1 038 069 deaths.7 Within Europe, over 5 431 510 cases are reported, with 226 869 deaths7 Presently there is no vaccine; therefore, preventing and limiting transmission is advocated. International and national evidence mandates physical distancing, regular hand hygiene and cough etiquette, and limiting touching eyes, nose or mouth; in addition to regular cleaning of surfaces.8

As noted older people are an at-risk group for COVID-19, and throughout the pandemic, the impact on this population has resulted in increased mortality, specifically those living in long term care facilities (LTCF) where a high proportion of outbreaks with increased rates of morbidity and case fatality in residents are recorded.9 In several EU/EEA countries, LTCF deaths among residents, associated with COVID-19, account for 37% to 66% of all COVID-19-related fatalities.9 The specific rationale for their increased susceptibility is less clear. The United Nations (UN) (2020) acknowledge that COVID-19 exposes the inequalities in society and the failures expressed in the 2030 Agenda for Sustainable Development. The UN report the disproportionate fatality rates in those aged over 80 years as five times the global average10 and suggest a need for a more *inclusive, equitable and age-friendly society, anchored in human rights* (p.16).11

The aim of this rapid review of the literature was to assess the extent to which measures implemented in LTCF reduced transmission of COVID-19 (SARS-CoV-2) among residents, staff, and visitors, and the effect of these measures on morbidity and mortality outcomes.

## Methods

The protocol is registered on PROSPERO (CRD42020191569)12 and reporting follows PRISMA guidelines.13

### Search strategy

Search strategies comprised search terms both for keywords and controlled-vocabulary search terms MESH and EMTREE (see Supplementary Table 1 for full search terms). EMBASE (via OVID), PubMed (via OVID), Cumulative Index to Nursing and Allied Health Literature (CINAHL), Cochrane Database and Repository, and MedRXiv pre-published databases were searched. No time limits were imposed, and databases were searched up to July 27, 2020. Reference lists of included evidence were checked for further articles.

### Eligibility criteria

All study designs (experimental, observational, and qualitative) are included, and no exclusions placed on language. Included studies report an assessment of measures to reduce transmission of COVID-19 (including SARS or MERS) in residents, employees, or visitors of LTCF. To provide as comprehensive a review of the evidence we included any intervention implemented to reduce the transmission of COVID-19 in long-term residential care facilities, including facility measures, social distancing, use of personal protective equipment, and hand hygiene.

### Primary outcome measures

Primary outcome measures are morbidity data, case fatality rates, reductions in reported transmission rates, and facility characteristics associated with COVID-19 incidence.

### Selection of studies and data extraction

Two authors developed search strings (DS & KF); all database searches were completed by one author (DS) (Supplementary Table 1). Following de-duplication, references were uploaded into Covidence management platform (LM), and two authors independently screened all titles and abstracts (LM & KF). Full texts of all potentially eligible studies were independently reviewed by two authors (LM & KF). Disagreements were resolved by discussion with a third author (CK). Data from included studies were independently extracted in duplicate (LM & KF). A data extraction form was developed and modified from documents used previously by authors (KF & CK). Extracted data included study characteristics (title, lead author, year of publication, country, study setting, study design), description of the intervention, number and characteristics of participants, outcomes, duration of follow-up, sources of funding, peer review status). Study design (required for review of quality) was independently assessed by two authors (LM & KF), with disagreements resolved by a third author (CK).

### Assessment of Quality

Two review authors (LM & EL) independently assessed the quality of included studies using Mixed Methods Assessment Tool (MMAT),14 with disagreements resolved by a third author (KF) and discussed with the lead author (CK) (Supplementary Table 2). The MMAT is used widely and considered a valid indicator of methodological quality using instruments for non-randomised and descriptive studies.

### Data synthesis

Meta-analysis was not possible due to heterogeneity in study designs, participants, outcomes, and nature of the interventions and no attempt was made to transform statistical data. The SWiM criteria15 guide a narrative summary, with data presented in tabular format and subgroup reporting of population groups.

## Results

We identified 1414 articles, and 131 full-text articles were selected for review. After an evaluation against our inclusion criteria, 38 studies (40 papers) are included in this systematic review (Figure 1).

![Figure 1](http://medrxiv.org/https://www.medrxiv.org/content/medrxiv/early/2020/11/03/2020.10.29.20222182/F1.medium.gif)

[Figure 1](http://medrxiv.org/content/early/2020/11/03/2020.10.29.20222182/F1)

Figure 1 PRISMA Flowchart

### Study characteristics

Geographically we report evidence from eleven countries, the majority (20 studies) are from USA16-35 and UK.36-40 We report evidence from Canada,41-43 France,44,45 Hong Kong,46,47 Belgium,48 Germany,49 Ireland,50 Japan,51 Korea,52 and Spain53 (Table 1).

View this table:
[Table 1.](http://medrxiv.org/content/early/2020/11/03/2020.10.29.20222182/T1)

Table 1. 
Characteristics of studies including infection control measures

### Infection control measures

Twenty studies report the nature of LTCFs related with outbreaks and transmission of COVID-19 infection (Table 2; 16,23,28,29,31,33,35-39,41-43,45-47,50-52). Thirty studies (Table 3a; 17-29,32-34,37-43,45-50,53) report evidence of measures to reduce transmission of COVID-19 in long-term residential care facilities for residents, 25 studies (Table 3b; 17-22,24,26-30,32,34,38,39,42-48,50,53) report evidence for employee outcomes, and two studies report evidence for visitors (Table 3c; 28,47).

View this table:
[Table 2.](http://medrxiv.org/content/early/2020/11/03/2020.10.29.20222182/T2)

Table 2. 
COVID-19 outcomes related to the nature of long term care facilities.

View this table:
[Table 3a.](http://medrxiv.org/content/early/2020/11/03/2020.10.29.20222182/T3)

Table 3a. 
Resident-specific outcomes of strategies implemented in nursing homes

View this table:
[Table 3b.](http://medrxiv.org/content/early/2020/11/03/2020.10.29.20222182/T4)

Table 3b. 
Staff-specific outcomes of strategies to reduce transmission

View this table:
[Table 3c.](http://medrxiv.org/content/early/2020/11/03/2020.10.29.20222182/T5)

Table 3c. 
Visitor-specific outcomes following the implementation of strategiesansmission

A variety of infection control measures are described (Tables 1 and 3a-c) including: mass testing/point-prevalence testing (22 studies; 17,19-22,25-30,32-34,38,39,44,45,48-50,53), use of personal protective equipment (10 studies; 17,18,20,25,28,29,32,45,47,49), screening of residents, staff, or visitors for symptoms (8 studies; 18-20,23,25,27,29,32), restrictions on visitor entry (10 studies; 18-20,25,27,29,32,45,49,53), hand hygiene and contact and droplet precautions (6 studies; 19,23,25,32,45,46), and cohorting/isolation of residents (11 studies; 19,20,22,25,28,29,32,33,45,47,49). Thirteen studies examined characteristics of LTCF and their association with COVID-19 infection and risk 16,24,31,35-37,39-43,51,52.

### Morbidity and mortality

Morbidity and mortality results from included studies are presented for residents (Table 3a), staff (Table 3b), and visitors (Table 3c). Prevalence of COVID-19 infection was reported in 29 studies, including prevalence in residents (27 studies; 17-29,32-34,38,39,41,43,45-50,53) and staff (22 studies; 17,19-22,24,26-30,32,34,38,39,44-48,50,53), with 2 studies reporting absolute case numbers in visitors.28,47 Prevalence rates ranged from 3.8% in a sample of 2074 LTCF48 and 1.2% in the third point-prevalence survey at a single facility20 to 85.4% in a single facility that implemented a telemedicine service to limit transmission.24 Staff prevalence ranged from 0.6% in a point-prevalence survey in a single facility20 to 62.6% in a group of nine LTCF.21 One study reported 16 COVID-19 positive visitor cases,28 while a study which examined SARS infection following an outbreak in a Hong Kong facility reported 3 positive visitor cases.47

The symptom status (symptomatic/presymptomatic/asymptomatic, typical/atypical symptoms) of participants was reported in 16 studies, with resident and staff symptom status reported in 15 17-19,21,22,25-27,29,32,33,45,48,50,53 and 13 studies,19-22,26,27,29,32,44,45,48,50,53 respectively. No studies reported symptom status of visitors. The proportion of COVID-19 positive residents presenting with symptoms ranged from 26.3%19,26 to 59.8% (a sample of both residents and healthcare workers).27 Asymptomatic cases in residents were reported in 13 studies,17,19,21,22,25-27,29,32,45,48,50,53 with proportions of COVID-19 positive residents presenting with no symptoms varying from 2.4%45 to 75.3%.48 Among COVID-19 positive staff, the proportion of symptomatic cases ranged from 6.4%26 to 100%,32 and asymptomatic cases ranged from 23.6%50 to 100%.20,22

Mortality results were reported in 22 studies, including information on mortality of residents (22 studies; 17-19,22-24,27-29,33,34,37-43,45,47,49,50), staff (4 studies; 28,34,45,47), and visitors (2 studies; 28,47). Mortality rates in COVID-19 positive residents ranged from 5.3%19 to 55.3%.38 One study reported a 66.7% death rate in residents who tested positive for the SARS virus.47 A study examining the mortality risk in Ontario LTCF reported a death rate of 0.1% across all residents.42 Across the three studies which presented mortality results in COVID-19 positive staff, mortality rates were 0%.28,34,45 One study presenting mortality rates in a nursing home following a SARS outbreak reported one death of a member of staff.47 Mortality rates reported in visitors in two studies was 0%47 and 6.2%,28 respectively.

### Characteristics of LTCFs on COVID-19 transmission

Numerous facility-specific characteristics were linked with risk of COVID-19 cases (Table 2). These include size of LTCF;16,37,38,51 staffing levels and/or use of agency care staff;28,31,36,38,39,43,50 part of larger chain of organisations and/or for profit status;16,31,35,42,43,50 and related staffing, crowding, or availability of single rooms.23,29,39,41,43,45-47

### Quality review

The quality ratings of included studies are presented in Supplementary Table 2. Overall quality of evidence in this review is considered low based on MMAT assessment criteria.

## Discussion

Evidence in this review indicates the impact of COVID-19 on LTCF, demonstrating the vulnerability of this setting. A novel outcome highlights the characteristics of LTCF associated with COVID-19 outbreaks, in addition to reporting the prevalence rates of COVID-19 and associated mortality and morbidity for residents, staff, and visitors. A variety of measures were implemented in LTCF, of which many were instigated locally by facility managers, and others through agile public health policy. Mass testing of residents with or without staff testing was the primary measure used to reduce transmission of COVID-19. This provides objective evidence of infection rates in facilities, and enables application of subsequent measures, including isolation of residents who are infected with re-designation of specific staff to care for them. Repeated point-prevalence testing allows facilities to grasp the spread of the virus along with the impact of their mitigation strategies.

Further measures implemented in facilities echoed public health recommendations to the broader community to limit the spread of the virus. These included guidance on hand hygiene, and contact and droplet precautions. Restricting visitor access to facilities was implemented generally to reduce the likelihood of introducing COVID-19 into LTCF, with assessment of body temperature and symptom screening of staff and visitors on entry.

The prevalence of COVID-19 infection varied throughout included studies, with no distinct pattern emerging between prevention strategies and infection prevalence. Similarly, the mortality rate varied widely among studies and prevention measures. However, patterns emerged regarding associations between facility characteristics and the risk of a COVID-19 outbreak and spread.

The facility size/number of beds was significantly associated with the probability of having a COVID-19 case, and the resulting size of an outbreak. For example, in a sample of 30 US nursing homes, the probability of having a COVID-19 case was increased in medium and large facilities compared with small facilities,16 while in 121 UK homes reporting an outbreak, facilities with ≥70 beds had 80% greater infection rates than facilities with <35 beds.38 A sample of 623 Canadian nursing homes demonstrated facilities with a high crowding index had more infections and deaths than those with a low crowding index. Simulations conducted suggested nearly 20% of infections and deaths may have been averted by converting all 4-bed rooms into 2-bed rooms.41 Similarly, facilities with a greater number of staff, staff who work in multiple facilities, and greater number of infected staff, were also more likely to experience a COVID-19 outbreak.36,39,50 However, facilities where staff receive sick leave were shown to be less likely to have positive cases.39 Reduced availability of PPE predicted the spread and increase in case number in facilities,36 while for-profit status of facilities was commonly identified as increasing the odds of case outbreaks relative to non-profit status.16,31,35,42,43

### Quality review

The quality of evidence in this review is technically low, primarily reported from observational studies, expert opinion, reporting of outbreaks and describing the process and management (Supplementary Table 2). Factors associated with lower quality of evidence includes the reliance of self-reporting of symptoms, recall bias, use of datasets which may be incomplete, and use of convenience sampling. However, confirmation of COVID-19 in the majority of studies was via laboratory testing. We did not remove any study following our review of quality and the evidence is consistent with real time reporting of data to learn from outbreaks. The Institute of Medicine (2004)54 advocates for early detection of epidemics, effective communication to the public, and promotion of research and development for strategic planning.

### Limitations in the review process

A key strength of this review is that it addresses a knowledge gap and has collated evidence from a broad methodological base to report the measures to reduce transmission of COVID-19 in LTFC and reports characteristics of facilities.

Due to the heterogeneity of studies, meta-analysis was not performed, while the descriptive nature of studies prevents identification of a causative relationship between measures and outcomes. Despite this, the systematic approach to this review has identified the scope of interventions implemented in LTFC to reduce COVID-19 transmission.

Publication bias was minimized with inclusion of pre-published evidence, follow up contacts with authors for early reporting, and through the inclusion of observational study designs. Most studies reported are in English, we translated papers from German and Spanish as part of the assessment and review. Outbreak reports include convenience samples or smaller cohorts of residents in LTCF with limited data reported in brief reports and letters. However, real time reporting of outbreaks provides immediate evidence and shared understanding advocated by the Institute of Medicine.54

While the present review builds on a review by Salcher-Konrad, Jhass, Naci, Tan, El-Tawil, Comas-Herrera 55, a recent report from WHO,56 and from an Irish review report,57 data on the role of facilities in the transmission of COVID-19 are reported.

## Conclusion

This novel, rapid review summarises the evidence base to date identifying specific factors for consideration as part of preparedness plans to reduce transmission of COVID-19 outbreaks in LTCF. Future research should incorporate methodologically robust study designs with longer follow up to assess the impact on reducing transmission.

## Supporting information

Supplementary file 1. Search strategy [[supplements/222182_file03.docx]](pending:yes)

Supplementary table. Quality ratings results [[supplements/222182_file04.docx]](pending:yes)

## Data Availability

Data available upon request

## Funding

Authors declare no funds were provided for the production of this review.

## Author Contributions

CK, KF, and LM designed the study; KF and DS developed the search strategy; DS conducted the literature search; KF and LM screened titles and full texts to select studies, and extracted data; LM, EL, KF, and CK conducted quality ratings; all authors interpreted and synthesised data; all authors were involved in writing. All authors have approved the final version of the manuscript.

## Conflicts of Interest

The authors declare no conflicts of interest. CK was a member of an expert panel investigating COVID-19 in nursing homes in Ireland.

*   Received October 29, 2020.
*   Revision received October 29, 2020.
*   Accepted November 3, 2020.


*   © 2020, Posted by Cold Spring Harbor Laboratory

The copyright holder for this pre-print is the author. All rights reserved. The material may not be redistributed, re-used or adapted without the author's permission.

## References

1.  1.European Centre for Disease Prevention and Control (ECDC). Timeline of ECDC’s response to COVID-19. 2020; [https://www.ecdc.europa.eu/en/covid-19/timeline-ecdc-response](https://www.ecdc.europa.eu/en/covid-19/timeline-ecdc-response). Accessed 4th October, 2020.
    
    

2.  2.World Health Organization. Coronavirus disease 2019 (COVID-19) Situation Report – 94. 2020.
    
    

3.  3.Nussbaumer-Streit B, Mayr V, Dobrescu AI, et al. Quarantine alone or in combination with other public health measures to control COVID-19: a rapid review. Cochrane Database Syst Rev. 2020;4(4):Cd013574 doi: 10.1002/14651858.cd013574.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1002/14651858.cd013574&link_type=DOI) 

4.  4.European Centre for Disease Prevention and Control (ECDC). Risk assessment: Outbreak of acute respiratory syndrome associated with a novel coronavirus, Wuhan, China. 2020; [https://www.ecdc.europa.eu/en/publications-data/rapid-risk-assessment-cluster-pneumonia-cases-caused-novel-coronavirus-wuhan](https://www.ecdc.europa.eu/en/publications-data/rapid-risk-assessment-cluster-pneumonia-cases-caused-novel-coronavirus-wuhan), 2020.
    
    

5.  5.World Health Organization. Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV).. 2020; [https://www.who.int/news-room/detail/30-01-2020-statement-on-the-second-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov)](https://www.who.int/news-room/detail/30-01-2020-statement-on-the-second-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-novel-coronavirus-(2019-ncov)).
    
    

6.  6.Meng X, Deng Y, Dai Z, Meng Z. COVID-19 and anosmia: A review based on up-to-date knowledge. Am J Otolaryngol. 2020;41(5):102581–102581 doi: 10.1016/j.amjoto.2020.102581.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/j.amjoto.2020.102581&link_type=DOI) 

7.  7.European Centre for Disease Prevention and Control (ECDC). COVID-19 situation update worldwide, as of 5 October 2020. 2020; [https://www.ecdc.europa.eu/en/geographical-distribution-2019-ncov-cases](https://www.ecdc.europa.eu/en/geographical-distribution-2019-ncov-cases). Accessed 5th October, 2020.
    
    

8.  8.European Centre for Disease Prevention and Control (ECDC). Surveillance of COVID-19 at longterm care facilities in the EU/EEA. Technical Report. 19 May 2020 2020.
    
    

9.  9.ECDC Public Health Emergency Team, Danis K, Fonteneau L, et al. High impact of COVID-19 in long-term care facilities, suggestion for monitoring in the EU/EEA, May 2020. Euro Surveillance. 2020;25(22):2000956 doi: 10.2807/1560-7917.ES.2020.25.22.2000956.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.2807/1560-7917.ES.2020.25.22.2000956&link_type=DOI) 

10. 10.United Nations. Policy Brief: The Impact of COVID-19 on older persons. May 2020.
    
    

11. 11.World Health Organization. Policy Brief: The Impact of COVID-19 on older persons. May 2020 2020.
    
    

12. 12.Frazer K, Mitchell L, Stokes D, Crawley E, Kelleher CC. Systematic review of measures to protect older people in long term care facilities from COVID 19. PROSPERO: International prospective register of systematic reviews. 2020;CRD42020191569
    
    

13. 13.Moher D, Liberati A, Tetzlaff J, Altman DG, The PRISMA Group. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Medicine. 2009;6(7):e1000097 doi: 10.1371/journal.pmed.1000097.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1371/journal.pmed.1000097&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=19621072&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F11%2F03%2F2020.10.29.20222182.atom) 

14. 14.Hong QN, Fàbregues S, Bartlett G, et al. The Mixed Methods Appraisal Tool (MMAT) version 2018 for information professionals and researchers. Education for Information. 2018;34:285–291 doi: 10.3233/EFI-180221.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.3233/EFI-180221&link_type=DOI) 

15. 15.Campbell M, McKenzie JE, Sowden A, et al. Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline. BMJ. 2020;368:6890 doi: 10.1136/bmj.l6890.
    
    [FREE Full Text](http://medrxiv.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiRlVMTCI7czoxMToiam91cm5hbENvZGUiO3M6MzoiYm1qIjtzOjU6InJlc2lkIjtzOjE3OiIzNjgvamFuMTZfMy9sNjg5MCI7czo0OiJhdG9tIjtzOjUwOiIvbWVkcnhpdi9lYXJseS8yMDIwLzExLzAzLzIwMjAuMTAuMjkuMjAyMjIxODIuYXRvbSI7fXM6ODoiZnJhZ21lbnQiO3M6MDoiIjt9) 

16. 16.Abrams HR, Loomer L, Gandhi A, Grabowski DC. Characteristics of U.S. Nursing Homes with COVID-19 Cases. Journal of the American Geriatrics Society. 2020 doi: 10.1111/jgs.16661.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1111/jgs.16661&link_type=DOI) 

17. 17.Arons MM, Hatfield KM, Reddy SC, et al. Presymptomatic SARS-CoV-2 infections and transmission in a skilled nursing facility. New England Journal of Medicine. 2020;382(22):2081–2090 doi: 10.1056/NEJMoa2008457.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1056/NEJMoa2008457&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=32329971&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F11%2F03%2F2020.10.29.20222182.atom) 

18. 18.Blackman C, Farber S, Feifer RA, Mor V, White EM. An Illustration of SARS-CoV-2 Dissemination Within a Skilled Nursing Facility Using Heat Maps. Journal of the American Geriatrics Society. 2020;68(10):2174–2178 doi: 10.1111/jgs.16642.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1111/jgs.16642&link_type=DOI) 

19. 19.Dora AV, Winnett A, Jatt LP, et al. Universal and Serial Laboratory Testing for SARS-CoV-2 at a Long-Term Care Skilled Nursing Facility for Veterans - Los Angeles, California, 2020. MMWR Morbidity and mortality weekly report. 2020;69(21):651–655 doi: 10.15585/mmwr.mm6921e1.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.15585/mmwr.mm6921e1&link_type=DOI) 

20. 20.Eckardt P, Guran R, Hennemyre J, et al. Hospital affiliated long term care facility COVID-19 containment strategy by using prevalence testing and infection control best practices. American Journal of Infection Control. 2020 doi: [https://doi.org/10.1016/j.ajic.2020.06.215](https://doi.org/10.1016/j.ajic.2020.06.215).
    
    

21. 21.Feaster M, Goh Y-Y. High Proportion of Asymptomatic SARS-CoV-2 Infections in 9 Long-Term Care Facilities, Pasadena, California, USA, April 2020. Emerging Infectious Disease journal. 2020;26(10):2416 doi: 10.3201/eid2610.202694.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.3201/eid2610.202694&link_type=DOI) 

22. 22.Graham N, Junghans C, Downes R, et al. SARS-CoV-2 infection, clinical features and outcome of COVID-19 in United Kingdom nursing homes. J Infect. 2020 doi: 10.1016/j.jinf.2020.05.073.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1016/j.jinf.2020.05.073&link_type=DOI) 

23. 23.Hand J, Rose EB, Salinas A, et al. Severe Respiratory Illness Outbreak Associated with Human Coronavirus NL63 in a Long-Term Care Facility. Emerg Infect Dis. 2018;24(10):1964–1966 doi: 10.3201/eid2410.180862.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.3201/eid2410.180862&link_type=DOI) 

24. 24.Harris DA, Archbald-Pannone L, Kaur J, et al. Rapid Telehealth-Centered Response to COVID-19 Outbreaks in Postacute and Long-Term Care Facilities. Telemedicine and e-Health. 2020;():ull doi: 10.1089/tmj.2020.0236.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1089/tmj.2020.0236&link_type=DOI) 

25. 25.Kimball A, Hatfield KM, Arons M, et al. Asymptomatic and Presymptomatic SARS-CoV-2 Infections in Residents of a Long-Term Care Skilled Nursing Facility - King County, Washington, March 2020. MMWR Morbidity and mortality weekly report. 2020;69(13):377–381 doi: 10.15585/mmwr.mm6913e1.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.15585/mmwr.mm6913e1&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=32240128&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F11%2F03%2F2020.10.29.20222182.atom) 

26. 26.Lennon NJ, Bhattacharyya RP, Mina MJ, et al. Comparison of viral levels in individuals with or without symptoms at time of COVID-19 testing among 32,480 residents and staff of nursing homes and assisted living facilities in Massachusetts. medRxiv. 2020:2020.2007.2020.20157792 doi: 10.1101/2020.07.20.20157792.
    
    [Abstract/FREE Full Text](http://medrxiv.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6NzoibWVkcnhpdiI7czo1OiJyZXNpZCI7czoyMToiMjAyMC4wNy4yMC4yMDE1Nzc5MnYxIjtzOjQ6ImF0b20iO3M6NTA6Ii9tZWRyeGl2L2Vhcmx5LzIwMjAvMTEvMDMvMjAyMC4xMC4yOS4yMDIyMjE4Mi5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=) 

27. 27.Louie JK, Scott HM, DuBois A, et al. Lessons from Mass-Testing for COVID-19 in Long Term Care Facilities for the Elderly in San Francisco. Clinical Infectious Diseases. 2020 doi: 10.1093/cid/ciaa1020.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1093/cid/ciaa1020&link_type=DOI) 

28. 28.McMichael TM, Currie DW, Clark S, et al. Epidemiology of covid-19 in a long-term care facility in King County, Washington. New England Journal of Medicine. 2020;382(21):2008–2011 doi: 10.1056/NEJMoa2005412.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1056/NEJMoa2005412&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=32220208&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F11%2F03%2F2020.10.29.20222182.atom) 

29. 29.Patel MC, Chaisson LH, Borgetti S, et al. Asymptomatic SARS-CoV-2 Infection and COVID-19 Mortality During an Outbreak Investigation in a Skilled Nursing Facility. Clinical Infectious Diseases. 2020 doi: 10.1093/cid/ciaa763.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1093/cid/ciaa763&link_type=DOI) 

30. 30.Quicke K, Gallichote E, Sexton N, et al. Longitudinal Surveillance for SARS-CoV-2 RNA Among Asymptomatic Staff in Five Colorado Skilled Nursing Facilities: Epidemiologic, Virologic and Sequence Analysis. medRxiv. 2020:2020.2006.2008.20125989 doi: 10.1101/2020.06.08.20125989.
    
    [Abstract/FREE Full Text](http://medrxiv.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6NzoibWVkcnhpdiI7czo1OiJyZXNpZCI7czoyMToiMjAyMC4wNi4wOC4yMDEyNTk4OXYyIjtzOjQ6ImF0b20iO3M6NTA6Ii9tZWRyeGl2L2Vhcmx5LzIwMjAvMTEvMDMvMjAyMC4xMC4yOS4yMDIyMjE4Mi5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=) 

31. 31.Quigley DD, Dick A, Agarwal M, Jones KM, Mody L, Stone PW. COVID-19 Preparedness in Nursing Homes in the Midst of the Pandemic. Journal of the American Geriatrics Society. 2020;68(6):1164–1166 doi: 10.1111/jgs.16520.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1111/jgs.16520&link_type=DOI) 

32. 32.Roxby AC, Greninger AL, Hatfield KM, et al. Outbreak Investigation of COVID-19 among Residents and Staff of an Independent and Assisted Living Community for Older Adults in Seattle, Washington. JAMA Internal Medicine. 2020 doi: 10.1001/jamainternmed.2020.2233.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1001/jamainternmed.2020.2233&link_type=DOI) 

33. 33.Sanchez GV, Biedron C, Fink LR, et al. Initial and Repeated Point Prevalence Surveys to Inform SARS-CoV-2 Infection Prevention in 26 Skilled Nursing Facilities — Detroit, Michigan, March–May 2020. MMWR Morb Mortal Wkly Rep. 2020;69:882–886 doi: [http://dx.doi.org/10.15585/mmwr.mm6927e1external](http://dx.doi.org/10.15585/mmwr.mm6927e1external).
    
    

34. 34.Telford CT, Onwubiko U, Holland D, et al. Mass Screening for SARS-CoV-2 Infection among Residents and Staff in Twenty-eight Long-term Care Facilities in Fulton County, Georgia. medRxiv. 2020:2020.2007.2001.20144162 doi: 10.1101/2020.07.01.20144162.
    
    [Abstract/FREE Full Text](http://medrxiv.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6NzoibWVkcnhpdiI7czo1OiJyZXNpZCI7czoyMToiMjAyMC4wNy4wMS4yMDE0NDE2MnYxIjtzOjQ6ImF0b20iO3M6NTA6Ii9tZWRyeGl2L2Vhcmx5LzIwMjAvMTEvMDMvMjAyMC4xMC4yOS4yMDIyMjE4Mi5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=) 

35. 35.Unruh MA, Yun H, Zhang Y, Braun RT, Jung H-Y. Nursing Home Characteristics Associated With COVID-19 Deaths in Connecticut, New Jersey, and New York. Journal of the American Medical Directors Association. 2020;21(7):1001–1003 doi: [https://doi.org/10.1016/j.jamda.2020.06.019](https://doi.org/10.1016/j.jamda.2020.06.019).
    
    

36. 36.Brainard JS, Rushton S, Winters T, Hunter PR. Introduction to and spread of COVID-19 in care homes in Norfolk, UK. medRxiv. 2020:2020.2006.2017.20133629 doi: 10.1101/2020.06.17.20133629.
    
    [Abstract/FREE Full Text](http://medrxiv.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6NzoibWVkcnhpdiI7czo1OiJyZXNpZCI7czoyMToiMjAyMC4wNi4xNy4yMDEzMzYyOXYxIjtzOjQ6ImF0b20iO3M6NTA6Ii9tZWRyeGl2L2Vhcmx5LzIwMjAvMTEvMDMvMjAyMC4xMC4yOS4yMDIyMjE4Mi5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=) 

37. 37.Burton JK, Bayne G, Evans C, et al. Evolution and impact of COVID-19 outbreaks in care homes: population analysis in 189 care homes in one geographic region. medRxiv. 2020:2020.2007.2009.20149583 doi: 10.1101/2020.07.09.20149583.
    
    [Abstract/FREE Full Text](http://medrxiv.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6NzoibWVkcnhpdiI7czo1OiJyZXNpZCI7czoyMToiMjAyMC4wNy4wOS4yMDE0OTU4M3YxIjtzOjQ6ImF0b20iO3M6NTA6Ii9tZWRyeGl2L2Vhcmx5LzIwMjAvMTEvMDMvMjAyMC4xMC4yOS4yMDIyMjE4Mi5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=) 

38. 38.Dutey-Magni PF, Williams H, Jhass A, et al. Covid-19 infection and attributable mortality in UK Long Term Care Facilities: Cohort study using active surveillance and electronic records (March-June 2020). medRxiv. 2020:2020.2007.2014.20152629 doi: 10.1101/2020.07.14.20152629.
    
    [Abstract/FREE Full Text](http://medrxiv.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6NzoibWVkcnhpdiI7czo1OiJyZXNpZCI7czoyMToiMjAyMC4wNy4xNC4yMDE1MjYyOXYxIjtzOjQ6ImF0b20iO3M6NTA6Ii9tZWRyeGl2L2Vhcmx5LzIwMjAvMTEvMDMvMjAyMC4xMC4yOS4yMDIyMjE4Mi5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=) 

39. 39.Office for National Statistics. Impact of coronavirus in care homes in England: 26 May to 19 June 2020. 2020.
    
    

40. 40.Stow D, Barker RO, Matthews FE, Hanratty B. National Early Warning Scores (NEWS / NEWS2) and COVID-19 deaths in care homes: a longitudinal ecological study. medRxiv. 2020:2020.2006.2015.20131516 doi: 10.1101/2020.06.15.20131516.
    
    [Abstract/FREE Full Text](http://medrxiv.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6NzoibWVkcnhpdiI7czo1OiJyZXNpZCI7czoyMToiMjAyMC4wNi4xNS4yMDEzMTUxNnYxIjtzOjQ6ImF0b20iO3M6NTA6Ii9tZWRyeGl2L2Vhcmx5LzIwMjAvMTEvMDMvMjAyMC4xMC4yOS4yMDIyMjE4Mi5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=) 

41. 41.Brown KA, Jones A, Daneman N, et al. Association Between Nursing Home Crowding and COVID-19 Infection and Mortality in Ontario, Canada. medRxiv. 2020:2020.2006.2023.20137729 doi: 10.1101/2020.06.23.20137729.
    
    [Abstract/FREE Full Text](http://medrxiv.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6NzoibWVkcnhpdiI7czo1OiJyZXNpZCI7czoyMToiMjAyMC4wNi4yMy4yMDEzNzcyOXYxIjtzOjQ6ImF0b20iO3M6NTA6Ii9tZWRyeGl2L2Vhcmx5LzIwMjAvMTEvMDMvMjAyMC4xMC4yOS4yMDIyMjE4Mi5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=) 

42. 42.Fisman DN, Bogoch I, Lapointe-Shaw L, McCready J, Tuite AR. Risk Factors Associated With Mortality Among Residents With Coronavirus Disease 2019 (COVID-19) in Long-term Care Facilities in Ontario, Canada. JAMA Network Open. 2020;3(7):e2015957–e2015957 doi: 10.1001/jamanetworkopen.2020.15957.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1001/jamanetworkopen.2020.15957&link_type=DOI) 

43. 43.Stall NM, Jones A, Brown KA, Rochon PA, Costa AP. For-profit long-term care homes and the risk of COVID-19 outbreaks and resident deaths. Cmaj. 2020;192(33):E946–e955 doi: 10.1503/cmaj.201197.
    
    [Abstract/FREE Full Text](http://medrxiv.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6NDoiY21haiI7czo1OiJyZXNpZCI7czoxMToiMTkyLzMzL0U5NDYiO3M6NDoiYXRvbSI7czo1MDoiL21lZHJ4aXYvZWFybHkvMjAyMC8xMS8wMy8yMDIwLjEwLjI5LjIwMjIyMTgyLmF0b20iO31zOjg6ImZyYWdtZW50IjtzOjA6IiI7fQ==) 

44. 44.Guery R, Delaye C, Brule N, et al. Limited effectiveness of systematic screening by nasopharyngeal RT-PCR of medicalized nursing home staff after a first case of COVID-19 in a resident. Médecine et Maladies Infectieuses. 2020 doi: [https://doi.org/10.1016/j.medmal.2020.04.020](https://doi.org/10.1016/j.medmal.2020.04.020).
    
    

45. 45.Sacco G, Foucault G, Briere O, Annweiler C. COVID-19 in seniors: Findings and lessons from mass screening in a nursing home. Maturitas. 2020;141:46–52 doi: [https://doi.org/10.1016/j.maturitas.2020.06.023](https://doi.org/10.1016/j.maturitas.2020.06.023).
    
    

46. 46.Heung LC, Li T, Mak SK, Chan WM. Prevalence of subclinical infection and transmission of severe acute respiratory syndrome (SARS) in a residential care home for the elderly. Hong Kong Med J. 2006;12(3):201–207.
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=16760548&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F11%2F03%2F2020.10.29.20222182.atom) 

47. 47.Ho WW, Hui E, Kwok TC, Woo J, Leung NW. An outbreak of severe acute respiratory syndrome in a nursing home. J Am Geriatr Soc. 2003;51(10):1504–1505 doi: 10.1046/j.1532-5415.2003.514841.x.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1046/j.1532-5415.2003.514841.x&link_type=DOI) 
    
    [PubMed](http://medrxiv.org/lookup/external-ref?access_num=14511179&link_type=MED&atom=%2Fmedrxiv%2Fearly%2F2020%2F11%2F03%2F2020.10.29.20222182.atom) 

48. 48.Hoxha A, Wyndham-Thomas C, Klamer S, et al. Asymptomatic SARS-CoV-2 infection in Belgian long-term care facilities. The Lancet Infectious Diseases. 2020 doi: [https://doi.org/10.1016/S1473-3099(20)30560-0](https://doi.org/10.1016/S1473-3099(20)30560-0).
    
    

49. 49.Klein A, Edler C, Fitzek A, et al. Der erste COVID-19-Hotspot in einer Hamburger Senioreneinrichtung. Rechtsmedizin. 2020;30(5):325–331 doi: 10.1007/s00194-020-00404-1.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1007/s00194-020-00404-1&link_type=DOI) 

50. 50.Kennelly SP, Dyer AH, Martin R, et al. Asymptomatic carriage rates and case-fatality of SARS-CoV-2 infection in residents and staff in Irish nursing homes. medRxiv. 2020:2020.2006.2011.20128199 doi: 10.1101/2020.06.11.20128199.
    
    [Abstract/FREE Full Text](http://medrxiv.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6NzoibWVkcnhpdiI7czo1OiJyZXNpZCI7czoyMToiMjAyMC4wNi4xMS4yMDEyODE5OXYxIjtzOjQ6ImF0b20iO3M6NTA6Ii9tZWRyeGl2L2Vhcmx5LzIwMjAvMTEvMDMvMjAyMC4xMC4yOS4yMDIyMjE4Mi5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=) 

51. 51.Iritani O, Okuno T, Hama D, et al. Clusters of COVID-19 in long-term care hospitals and facilities in Japan from 16 January to 9 May 2020. Geriatrics & Gerontology International. 2020;20(7):715–719 doi: 10.1111/ggi.13973.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.1111/ggi.13973&link_type=DOI) 

52. 52.Kim T. Improving Preparedness for and Response to Coronavirus Disease 19 (COVID-19) in Long-Term Care Hospitals in the Korea. Infect Chemother. 2020.
    
    

53. 53.Borras-Bermejo B, Martínez-Gómez X, San Miguel MG, et al. Asymptomatic SARS-CoV-2 Infection in Nursing Homes, Barcelona, Spain, April 2020. Emerging Infectious Disease journal. 2020;26(9):2281 doi: 10.3201/eid2609.202603.
    
    [CrossRef](http://medrxiv.org/lookup/external-ref?access_num=10.3201/eid2609.202603&link_type=DOI) 

54. 54.1.  Knobler S, 
    2.  Mahmoud A, 
    3.  Lemon S, 
    4.  Mack A, 
    5.  Sivitz L, 
    6.  Oberholtzer K
    
    Institute of Medicine (IOM). Learning from SARS: Preparing for the Next Disease Outbreak: Workshop Summary. In: Knobler S, Mahmoud A, Lemon S, Mack A, Sivitz L, Oberholtzer K, eds. Learning from SARS: Preparing for the Next Disease Outbreak: Workshop Summary. Washington (DC): National Academies Press (US), Copyright © 2004, National Academy of Sciences.; 2004.
    
    

55. 55.Salcher-Konrad M, Jhass A, Naci H, Tan M, El-Tawil Y, Comas-Herrera A. COVID-19 related mortality and spread of disease in long-term care: a living systematic review of emerging evidence. medRxiv. 2020:2020.2006.2009.20125237 doi: 10.1101/2020.06.09.20125237.
    
    [Abstract/FREE Full Text](http://medrxiv.org/lookup/ijlink/YTozOntzOjQ6InBhdGgiO3M6MTQ6Ii9sb29rdXAvaWpsaW5rIjtzOjU6InF1ZXJ5IjthOjQ6e3M6ODoibGlua1R5cGUiO3M6NDoiQUJTVCI7czoxMToiam91cm5hbENvZGUiO3M6NzoibWVkcnhpdiI7czo1OiJyZXNpZCI7czoyMToiMjAyMC4wNi4wOS4yMDEyNTIzN3YzIjtzOjQ6ImF0b20iO3M6NTA6Ii9tZWRyeGl2L2Vhcmx5LzIwMjAvMTEvMDMvMjAyMC4xMC4yOS4yMDIyMjE4Mi5hdG9tIjt9czo4OiJmcmFnbWVudCI7czowOiIiO30=) 

56. 56. World Health Organization. Preventing and managing COVID-19 across long-term care services: policy brief. Geneva2020. WHO/2019-nCoV/Policy\_Brief/Long-term\_Care/2020.1.
    
    

57. 57.Kelleher CC, Doherty B, Donnelly P, Twomey C. COVID-19 Nursing Homes Expert Panel. Examination of Measures to 2021. Report to the Minister for Health. 2020.